April 2019 Funding Opportunities and Announcements
Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
Prostate Cancer Foundation 2019 PCF Challenge Awards
The foundation requests Team Science Applications addressing Metastatic Lethal Prostate Cancer; high-risk, currently unfunded applications are most desired. The foundation especially seeks research in VA hospitals, where research directly affects veterans with prostate cancer. Proposals in the following topic areas are preferred: Immunotherapy; targeted radionuclide therapy; new systemic precision treatments targeting those previously deemed "undruggable"; first-in-field research; mechanisms of resistance to current and investigational drugs targeting androgen receptor and axis; correlative research around either clinical trials of novel agents or strategies or standard of care; developing or validating biomarkers; tumor microenvironment signaling; and new data science technologies for analysis of genomic information to advance prevision medicine.
Deadline: April 22, 2019
Amount and Project Period: $1M over 2 years
Eligibility : Team must be composed of 3 investigators capable of providing unique scientific expertise and may be from the same institution or multiple institutions. Must include at least one young investigator integral to the team. "Young Investigator" must be within 6 years of completing a professional degree and can have received no more than $200,000 in prior research funding.
Reviewers: Peer review committee
Brain Research Foundation Scientific Innovations Award
Limited Submission Opportunity
The objective of the SIA is to support projects in both basic and clinical neuroscience that may be too innovative and speculative for traditional funding sources, but still have a high likelihood of producing important findings. The funding mechanism is designed to support creative, exploratory, cutting-edge research in well-established research laboratories, under the direction of established investigators. The BRF funds innovative neuroscience research that expands understanding of how the brain works, and provides educational programs for researchers, families struggling with debilitating brain disorders and the general public. The BRF plays a critical role in the scientific process by funding grants that are the starting blocks to discovery, allowing scientists to prove the feasibility of their projects and produce data that will make them eligible for larger government and institutional funds. This grant is not to be used as bridge funding for a current project; the proposal should detail a new research project that is not funded by other sources.
Deadline: April 25, 2019 (internal)
Amount and Project Period: $150,000 over 2 years
Eligibility : Full-time associate or full professor working in the area of studies of brain function in health and disease. Current major NIH or other peer-reviewed funding is preferred, but evidence of such funding in the past 3 years is essential. Studies should be related to either normal human brain development or specifically identified disease states. This includes molecular and clinical neuroscience, as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. This grant is not to be used as bridge funding. Scientists who have received a BRF Scientific Innovations Award may not receive the award for a second time until 5 years has elapsed since the beginning date of the prior award. Proposal must detail a new research project that is not funded by other sources.
Required Materials and Process for GW's Selection Committee: OVPR InfoReady Link
Ovarian Cancer Research Alliance Liz Tilberis Early Career Award
This award is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent is to support a substantial time commitment to research and academic endeavors in ovarian cancer. Applicants must be working in institutions with strong existent ovarian cancer research programs. The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of early detection, prevention, treatment, and translational ovarian cancer research.
Deadline: April 28, 2019 (LOI)
Amount and Project Period: $450,000 over 3 years with option to extend
Eligibility : Applicants must have a DO, MD, and/or a PhD degree and should be in the first seven years of their first academic appointment after having completed a fellowship or postdoctoral training. For applicants without clinical responsibilities, at least 75% of their time must be dedicated to ovarian cancer research.
Reviewers: All LOIs will be reviewed by the OCRA's Scientific Advisory Committee, which is comprised of distinguished members of the medical, research and patient advocacy community from across the U.S.
Ovarian Cancer Research Alliance Collaborative Research Development Grant
The purpose of this grantmaking program is to provide funds for ovarian cancer research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged. The section committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics. Submissions that focus on health services research, quality of life, and epidemiology are also encouraged.
Deadline: April 28, 2019 (LOI)
Amount and Project Period: $900,000 over 3 years
Eligibility : PI(s) and other investigators have to have full-time faculty appointments in a school of medicine or public health. PIs should not be in a training program and should be at least 5 years post-training. For multi-PI submissions, at least one PI must be a physician with expertise in ovarian cancer. For single PI submissions, a key investigator must be a physician with expertise in ovarian cancer. The primary review criteria will be the likelihood that investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding.
Reviewers: All LOIs will be reviewed by the OCRA's Scientific Advisory Committee, which is comprised of distinguished members of the medical, research and patient advocacy community from across the U.S.
Ovarian Cancer Research Alliance Ann and Sol Schreiber Mentored Investigator Award
This grant provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or a related area. The selection committee will consider the strength of the research environment and project proposal, the trainee's prior academic record, and the likelihood that he/she will pursue a research career dedicated to ovarian cancer.
Deadline: April 28, 2019 (LOI)
Amount and Project Period: $75,000
Eligibility : Applicants must be either clinical fellows or postdoctoral fellows with protected time to do the proposed work. Candidates must have an MD or PhD. PhD applicants must be no more than 5 years out of their terminal degree at time of application and MD and MD/PhD's must currently be enrolled in a fellowship program.
Reviewers: All LOIs will be reviewed by the OCRA's Scientific Advisory Committee, which is comprised of distinguished members of the medical, research and patient advocacy community from across the U.S.
Alex's Lemonade Stand Foundation "A" Award Grants
The "A" Award is designed for the early independent career scientist who wants to establish a career in pediatric oncology research. The ideal candidate has an original project, can demonstrate outstanding career development support from the institution, and has a strong future commitment to pediatric cancer investigation. These awards are open to MD, MD/PhD or dual MD/PhD and be within five years of their first faculty appointment as an assistant professor. The "A" Award offers up to $200,000 per year for four years, with the possibility of a fifth year of funding.
Deadline: May 20, 2019
Amount and Project Period: $800,000 over 4 years with option for one additional year
Eligibility : Proposals must be aligned with ALSF's mission and "A" Award program goals. Applicants must have an MD, PhD, or dual MD/PhD and be within five years of their first faculty appointment as an assistant professor. A minimum of 75% of the applicant's time must be allotted as protected for all research activities. Applicants can have other active research grants, but there must not be time or budget overlap. Investigators cannot have received a K99/R00 or R01 that has been funded or recommended for funding at the time of this application.
Reviewers: Scientific Boards
National Institutes of Health: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
Funding Opportunity Announcement PA-18-932 invites applications that seek to develop and understand strategies to reduce disparities in the uptake of evidence-based screening. Research supported by this initiative should enhance the screening process in diverse populations, in diverse clinical and community settings, and/or with traditional, non-traditional, and/or allied health care providers.
Deadline: June 5, 2019
Amount and Project Period: Varies, maximum project period is 5 years
Eligibility : Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NH support.
Reviewers: Peer Review
Chordoma Foundation Clinical Trials Program
Under this RFP, the foundation aims to identify one or more new therapeutic concepts with strong scientific rationale. Awards will be given in support of well-justified clinical trials designed to determine whether, and to what extent, promising new therapies can improve the lives of chordoma patients. Mechanisms of support offered through this RFP include trial initiation assistance and patient education and outreach, with grants of up to $300,000 awarded to fund non-drug study costs of investigator-initiated trials.
Deadline: May 10, 2019
Amount and Project Period: $300,000
Eligibility : Investigators at all career levels are eligible to apply.
American Association for Cancer Research - MPM Capital
This program is intended to stimulate high-risk, high-reward research by early- to mid-career investigators and promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that grants awarded through the program will catalyze significant scientific discoveries that advance understanding of cancer and have a potentially transformative impact on future clinical practice. Through the program, grants of up to $400,000 over two years will be awarded for any type of basic, translation, or clinical research.
Deadline: May 10, 2019
Amount and Project Period: $400,000
Eligibility : Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree; hold an appointment at the level of assistant or associate professor by the start of the grant term (November 1, 2019) and be an AACR member in good standing.